Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) Income towards Parent Company (2025 - 2026)

IceCure Medical has reported Income towards Parent Company over the past 2 years, most recently at $4.2 million for Q1 2026.

  • For Q1 2026, Income towards Parent Company rose 16.13% year-over-year to $4.2 million; the TTM value through Mar 2026 reached $7.9 million, up 116.13%, while the annual FY2025 figure was -$15.1 million, 3.84% up from the prior year.
  • Income towards Parent Company was $4.2 million for Q1 2026 at IceCure Medical, up from $3.7 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $4.2 million in Q1 2026 and bottomed at $3.7 million in Q1 2025.